The Problem

Opioid addiction has reached epidemic levels in the United States and worldwide. Opioid and heroin is now the #1 cause of accidental death in Canada and the USD for people under 50. At all stages, it destroys families. The opioid crisis cost the US $696 billion in 2018 - or 3.4 percent of GDP - and more than $2.5 trillion for the four-year period from 2015 to 2018.

Devastating families
Straining the economy
Current detox methods leave patcients re-addiction-prone

The Solution

Ibogaine works differently from other drug treatments; it resets the receptors in the brain and normalizes brain waves.

Ibogaine's long-lasting metabolite decreases or eliminates cravings and removes the overwhelming compulsion to use drugs for approximately 2-4 months following treatment. Ibogaine's long-lasting metabolite decreases or eliminates cravings and removes the overwhelming compulsion to use drugs for approximately 2-4 months following treatment.

  • Extremely fast acting, plant-based, naturally-occurring substance.
  • Paired with our treatment protocol it alleviates withdrawal symptoms and interrupts the process of active addiction.
  • Our detox treatment eliminates 95% of symptoms associated with opioid withdrawal.

Operation Milestones

  • Open a clinic in the Czech Republic
  • Open follow up clinics over the globe
  • Approval of our patented treatment protocol by Health Canada for research in Canada
  • Commencement of clinical trails in Canada in mid-2020
  • Patented treatment protocol approved by Health Canada and open up franchises across Canada becoming the first licensed ibogaine treatment centres in North America

With our powerful team of experienced professionals and pioneers of ibogaine treatment, coupled with the magnitude of the problem we are solving, we are positioned in a key place for success. Our balance between medical expertise, corporate development, and capital markets knowledge ensures our ability to follow through on our plans and bring successful treatments to our clients.

The opioid epidemic has never been so devastating. People all over the world have been affected and unless this treatment is rolled out worldwide it will continue to get exponentially worse. By going public we allow everyone to be a part of the solution and gain additional funding to be able to expand rapidly in response to the demand for this treatment all over the world.

"Make big ones out of little ones."
-Shayne Nyquvest

The first few days after entering our clinic we stabilize the patients and prepare them mental and physical for the ibogaine treatment. During this time we also run various tests to verify the mental and physical state the patient claims to be in. It is imperative for the effectiveness and safety of our treatment that no questions are left unanswered.


Next, we connect them to an IV for fluids and carefully give the patient the correct number of ibogaine pills for it be a safe and effective detox. All the while an MD is nearby and a RN is present continually monitoring the patient's vitals. With our patented treatment protocol the detox only takes 18 hours and is nearly painless. Our treatment protocol resets the patient's neurochemistry within 45 minutes of administration.


After the treatment we take a glass half-full approach with life coaching and recommendations of long term rehab. The patient doesn't have withdrawal or the urge to use but there are still many unsolved issues in their life. We prepare the patient for the issues they're going to face when they return and help the patient navigate through the wreckages of their past.


Investment Case

We are in a unique position in history where the epidemic has never reached such devastating sizes. By being part of the solution to such an enormous epidemic we are creating the next multi-billion dollar industry.

  • We have already provided 3400 treatments with our safety protocol with astonishing results
  • We will undertake clinical trails in Canada in 2020
  • We have a rapid path to positive cash flow
  • A global business: we project treating over 23,000 patients by 2025 through 52 clinics globally
  • We are seeking only $3.8 Million USD to implement our business plan
  • We are expecting to be listed on the TSX.V in 2020

Get your detailed investment information package now!

Request access


Dr. Alberto Sola

  • Dr. Alberto Sola, Universal Ibogiane's President, is a thought leader in entheogenic treatment. He has the distinction of having treated more patients with ibogaine than any other person in the world and is head of operations at Clear Sky Recovery. Dr. Sola graduated from Univsersidad Anahuac. As the Medical Director of Amerimed, he opened four emergency hospitals in Puerto Vallarta, Cancun, and Cabo San Lucas.

Hirpal Hundial

  • Hirpal Hundial, RN, BSN, MSN, is a Registered Nurse and Nursing Practice Consultant with background in critical care. She has worked closely with the B.C. Supreme Court on numerous occasions regarding patient safety, designed the Safe Care Nursing Framework and is a patient safety educator certified by the Canadian Patient Safety Institute.

Dr. William Dick

  • Dr Dick is a practising emergency medicine physician and clinical researcher based at the University of British Columbia. He has extensive administrative and front-line experience in substance use disorder policy and treatment. Dr Dick’s research work includes novel pain control methods, cardiac resuscitation and emergency health system redesign. In his previous position as Vice-President Medical Programs, BC Emergency Health Services, he worked closely with governments, public health agencies and emergency health providers to help facilitate the provincial response to the current opioid overdose epidemic.

Can't decide? Don't hesitate to contact us!

Shayne Nyquvest

  • Shayne Nyquvest is the former Executive Vice President of Mackie Research Capital and a founding member of the Canaccord Genuity Group. Nyquvest can personally vouch for the transformational effects of ibogaine and aims to see this treatment adopted by the mainstream medical community as an answer to the opioid epidemic.

Patrick K. Kroupa

  • Patrick K. Kroupa is a writer and entrepreneur who survived addiction through the use of ibogaine. Kroupa co-founded MindVox, the first internet service provided in New York City and was one of the original co-founders of Clear Sky. His work has been featured in The New Yorker, Forbes, and the New York Times. Kroupa authored numerous research papers on ibogaine, including being the primary author of he first study on the benefits of micro-dosing and fraction-dosing ibogaine ever published.

Shabir Premji

  • Shabir Premji is a businessman and a serial entrepreneur. He is the Chairman and CEO of P Squared Renewables Inc., a TSX.V listed company through which Universal Ibogaine is expected to go public. He was the Founder and Executive Chairman of Alberta Oilsands, a TSX.V listed company that raised nearly $100 million in the capital markets and successfully found over 300 million barrels of bitumen reserves, merged its Kenya mineral rights into Africa Oil Inc., which successfully raised nearly $1 billion and found huge oild reserves in Kenya. Mr. Premji qualified as a Charter Accountant in England and Alberta. He was a Senior Manager with KPMG prior to moving in managing commercial enterprises




Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form

Phone Number

+1 (604) 283-0900

Get your detailed investment information package now!

Request access